Find Federal Grants | GrantBeacons

Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-DA-19-022

Closes: Mar 19, 2019

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-163

Closes: Jan 7, 2022 Up to: $200,000

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-162

Closes: Jan 7, 2022

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · PAR-19-153

Closes: Jan 7, 2022 Up to: $200,000

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-149

Closes: Jan 7, 2022 Up to: $200,000

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · PAR-19-150

Closes: Jan 7, 2022 Up to: $200,000

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

★ Save Archived

National Institutes of Health · PAR-19-159

Closes: May 7, 2022

Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-146

Closes: Jan 7, 2022 Up to: $200,000

Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-147

Closes: Jan 7, 2022

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-158

Closes: May 7, 2022

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-026

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-025

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-024

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-023

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-027

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-028

Closes: Sep 27, 2019 Up to: $150,000

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-019

Closes: Sep 27, 2019 Up to: $200,000 Program funding: $4,200,000

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-020

Closes: Sep 27, 2019 Up to: $300,000 Program funding: $4,300,000

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-021

Closes: Sep 27, 2019 Up to: $200,000 Program funding: $1,000,000

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-022

Closes: Sep 27, 2019 Up to: $300,000 Program funding: $900,000